SciVision Biotech Inc
TWSE:1786

Watchlist Manager
SciVision Biotech Inc Logo
SciVision Biotech Inc
TWSE:1786
Watchlist
Price: 114 TWD 2.24% Market Closed
Market Cap: 8.2B TWD
Have any thoughts about
SciVision Biotech Inc?
Write Note

SciVision Biotech Inc
Investor Relations

SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2010-12-29. The firm primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The firm is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The firm operates its business in the Americas, Europe, Asia, Middle East and Africa.

Show more

Earnings Calls

No Earnings Calls Available

Management

Tai Xian Han
General Manager and Director
No Bio Available
Ru Ling Guo
VP, Financial Officer & Accounting Officer
No Bio Available

Contacts

Address
KAOHSIUNG
Kaohsiung
No.1, South 1st Road
Contacts